<code id='7DC82135BD'></code><style id='7DC82135BD'></style>
    • <acronym id='7DC82135BD'></acronym>
      <center id='7DC82135BD'><center id='7DC82135BD'><tfoot id='7DC82135BD'></tfoot></center><abbr id='7DC82135BD'><dir id='7DC82135BD'><tfoot id='7DC82135BD'></tfoot><noframes id='7DC82135BD'>

    • <optgroup id='7DC82135BD'><strike id='7DC82135BD'><sup id='7DC82135BD'></sup></strike><code id='7DC82135BD'></code></optgroup>
        1. <b id='7DC82135BD'><label id='7DC82135BD'><select id='7DC82135BD'><dt id='7DC82135BD'><span id='7DC82135BD'></span></dt></select></label></b><u id='7DC82135BD'></u>
          <i id='7DC82135BD'><strike id='7DC82135BD'><tt id='7DC82135BD'><pre id='7DC82135BD'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:11
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
          Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

          YichuanCao/SipaUSAGileadSciencessaidMondayitwillacquireCymaBayTherapeuticsfor$4.3billion,addinganewt

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Data show record exodus of life scientists from academia

          AdobeNewdatareleasedThursdaybytheNationalScienceFoundationshowtheexodusofyounglifescientistsfromtheI